author-photo

Jose M. Pacheco

University of Colorado Boulder

53

Papers

411

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Abstract LB050: Modulation of innate and adaptive immunity in blood and tumor of patients receiving the SHP2 inhibitor RMC-4630

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC.

2021 Journal of Thoracic Oncology
- Jose M. Pacheco
- Erin L. Schenk
Show All
- Source
- Cite
- Save
Citations (0)
Optimal Therapy for advanced NSCLC without driver alterations

2021 JNCI Cancer Spectrum
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB054: Confirmation of target inhibition and anti-tumor activity of the SHP2 inhibitor RMC-4630 via longitudinal analysis of ctDNA in a phase 1 clinical study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Abstract LB001: Anti-tumor activity and tolerability of the SHP2 inhibitor RMC-4630 as a single agent in patients with RAS-addicted solid cancers

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Mobocertinib: A Potential Treatment for NSCLC with EGFR Exon 20 Insertions

2021 Cancer Discovery
- Jose M. Pacheco
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study of OKI-179, an oral class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors: Final results.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (9)
Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors.

2021 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (0)